Say hey to Aktivolabs! This Singaporean startup is building personalized and evidence-based solutions to help you live long, healthy lives and manage your risk of chronic diseases. Now, they've just raised a $10M Series A!

• Founded in 2017, they're active in over ten markets, including Singapore, the Philippines, Indonesia and Malaysia.
• Their products include the Aktivo Score, Aktivo Mind, Glucolife and Goodbiome.

Investor check. Mitsui & Co, Adaptive Capital Partners, SEEDS Capital, HH Investments and Govin Capital joined in!

‍

🗓 A score a day

Keeps the chronic illness away! They're best known for their Aktivo app that allows you to track data on your real-time health. And based on data on you and your lifestyle, they'll generate a daily Aktivo Score that measures your long-term health and risk of chronic disease.

• Their app receives real-time health data from your fitness tracker or your Apple Health app.
• They track your physical activity, weight, sleep, blood glucose, blood pressure and more!

The challenge? Keep that daily score as high as possible. To do that, you'll have to make

• A score of 80 or above is ideal, but scoring below 60 regularly could lead to chronic diseases.

‍

🤓 For you, for your insurers and even your boss.

For you. Aktivo will help you make informed decisions to improve your lifestyle and health.

• Fun to be healthy. Plus, you can even set challenges with family and friends, as well as share on Aktivo's social feature.

For your insurers. Aktivo's data allows insurers to launch more personalized products, acquire higher-value customers, underwrite (aka, evaluate insurance risk) faster and more effectively and better support their customers.

For your team. They also have B2B corporate health programs! This gives your team access to the Aktivo app to improve their lifestyles and be more engaged. Healthy teams produce better work!

• You'll even get reports on how your team is engaging and on their health progress.

‍

💰 What's with the $$$?

They'll be doubling down on their data science capabilities to make predicting, preventing and self-managing chronic disease way better. They'll also be leveling up the team, growing their existing verticals and expanding across SEA, Europe and the US.